Teva intros new dosage strength of Focalin XR generic
NORTH WALES, Penn. — Teva announced Monday that it had introduced its generic version of Focalin XR (dexmethylphenidate hydrochloride) extended-release capsules in a new 20-mg dosage strength. The drug, which is used to treat attention deficit hyperactivity disorder, is now available from Teva in 5-, 10-, 15-, 20-, 30- and 40-mg strengths.
“Our customers count on Teva for a continuous supply of new generic products,” Teva’s SVP, U.S. generic sales and marketing Maureen Cavanaugh said. “With the launch of dexmethylphenidate hydrochloride extended-release capsules, CII, in a 20-mg strength we add another quality product to our broad line of affordable generic pharmaceuticals.”
Diplomat acquires Burman’s Specialty Pharmacy
FLINT, Mich. — Diplomat Pharmacy announced Friday that it had acquired the Pennsylvania-based Burman’s Specialty Pharmacy for $72.8 million in cash and $10 million in Diplomat common stock. The acquisition has expanded Diplomat’s hepatitis C specialty services, as Burman’s individualized patient care is focused primarily on those with Hepatitis C.
“Burman's shares our strong commitment to patient care,” Diplomat CEO and chairman Phil Hagerman said. “We acquired Burman's to enhance our targeted clinical management programs, utilize its innovative hepatitis C technology platform and strong payer network, and increase our presence in the U.S. mid-Atlantic region.”
Burman’s uses HealthTrac software, which allows pharmacists and providers to collaborate more on patient care and can be especially helpful for patients with hepatitis C.
“Diplomat's patient-centric focus echoes our own approach,” Steve Burman, president and CEO of Burman’s said. “We pride ourselves on improving patient care with innovative technology. HealthTrac opens the lines of communication between all healthcare professionals involved to improve treatment efficiency in an effort to both improve results and reduce costs. Diplomat shares that vision and puts it into practice with high-touch patient care.”
“We believe the HealthTrac technology will significantly expand our hepatitis C services across our national footprint,” Hagerman said.
HRG’s Dave Wendland to present ‘Seven Deadly Sins of Community Pharmacy’ at McKesson ideaShare
WAUKESHA, Wis. — Dave Wendland, VP and member of the owners group at Hamacher Resource Group, will present a continuing education session, “Seven Deadly Sins of Community Pharmacy,” at the upcoming McKesson ideaShare 2015 conference.
The presentation, to be held June 25 from 1:30 p.m. to 3 p.m., will center on the most common challenges community pharmacies face trying to grow their front end.
Pharmacists attending will learn several key points during the session, including how to identify areas for improvement, key components essential for an effective front-end, and techniques to evaluate what is and isn’t working and how to enact change. The insights and recommendations are based on the hundreds of store visits and pharmacy assessment projects HRG has performed over the years.
HRG provides McKesson and its Health Mart pharmacies best practice solutions for the front of store.
“We’ve enjoyed a long-term strategic partnership with McKesson. Over the years, we’ve provided innovative category management tools for their independent pharmacies and have been asked to share our expertise via CE sessions at their annual conference. We are proud to be asked back to ideaShare this year and present a CE session to help pharmacists improve their front-end practices,” stated Tom Boyer, director of national accounts and member of the HRG owners group.